WE
AVDL

Wealth Effects’s Avadel Pharmaceuticals AVDL Stock Holding History

Wealth Effects’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– -$431K – 239
2025
Q4 		– Hold
0
– – – 120

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wealth Effects's AVDL Position: Q1 2026 in Review

Wealth Effects sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 1,891,917 shares — an estimated $40.8M sold.

Wealth Effects first reported a position in AVDL in Q4 2021 and held it in 17 quarters. The position peaked at $40.8M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Wealth Effects reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Wealth Effects sold 1,891,917 Avadel Pharmaceuticals shares in Q1 2026, an estimated $40.8M.
  • Wealth Effects first reported a position in Avadel Pharmaceuticals in Q4 2021 and held it in 17 quarters.
  • Wealth Effects's Avadel Pharmaceuticals position peaked at $40.8M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.